Extracorporeal Membrane Oxygenation Machine (ECMO) Market Highlights
The Extracorporeal Membrane Oxygenation Machine (ECMO) Market is expected to grow at a CAGR of 5.10% and value USD 710.20 million during the forecast period 2020 to 2030.
Extracorporeal membrane oxygenation machine is also known as a life support machine. It is used in the treatment of various heart and lung disease. The main function of extracorporeal membrane oxygenation machine is to provide enough oxygen to the body when heart and lung are not functioning properly. This machine is used in the treatment of lung cancer and various other chronic disorders. The Extracorporeal Membrane Oxygenation Machine (ECMO) Market overview report says that the industry is driven by various factors such as increasing geriatric population, rising prevalence rates of lung cancer, and other chronic diseases. However, the high cost of surgery and increasing side effect after the treatment is expected to curb the growth of the Extracorporeal Membrane Oxygenation Machine (ECMO) Market.
The global Extracorporeal Membrane Oxygenation Machine (ECMO) Market is currently dominated by several market players. The key players are involved in new product launches and strategic collaborations to strengthen its market position.
Segmentation
The global Extracorporeal Membrane Oxygenation Machine (ECMO) Market has been segmented based on component, modality, and application.
The market, based on component, has been divided into pumps, oxygenators, controllers, cannula, and accessories. The oxygenators segment is likely to hold a major share in the market due to the increasing adoption of extracorporeal membrane oxygenation machine for cardiac treatments. The pumps segment is predicted to be the fastest-growing due to the increasing incidences of asthma.
The market on the basis of modality is further segmented into veno-arterial (VA), veno-venous (VV), and arterio-venous (AV). The veno-arterial segment is expected to hold a major share in the market due to its widespread use in the treatment of cardiovascular collapse. Whereas veno-venous segment is expected to be the fastest-growing due to its increasing use in cardiogenic shock.
The market on the basis of application is further segmented into respiratory, cardiac, and extracorporeal cardiopulmonary resuscitation (ECPR). The respiratory segment is expected to hold the major share in the market due to its crucial role in supporting pulmonary function and is projected to witness lucrative growth over the forecast period whereas the extracorporeal cardiopulmonary resuscitation segment is expected to be the fastest-growing due to the rising incidence of cardiac illness worldwide.
Key Players
Some of the key Extracorporeal Membrane Oxygenation Machine (ECMO) Market players are Getinge Group, Medtronic, Livanova PLC, Abbott, Agilent Technologies, Siemens AG, Terumo Corporation, Fresenius Medical Care AG & Co. KGaA, Microport Scientific Corporation, Nipro Corporation, ALung Technologies, Inc., MAQUET Holding B.V. & Co. KG, Medos Medizintechnik AG, Terumo Cardiovascular Systems Corp, and Others.
Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Extracorporeal Membrane Oxygenation Machine (ECMO) Market size in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European Extracorporeal Membrane Oxygenation Machine (ECMO) Market has been sub-divided Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, UK, Italy, Spain, and the rest of Western Europe. The Extracorporeal Membrane Oxygenation Machine (ECMO) Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Extracorporeal Membrane Oxygenation Machine (ECMO) Market in the Middle East & Africa has been divided into the Middle East and Africa.
Related Report
Retropharyngeal Abscess Market
Europe, the Middle East and Africa Gastrointestinal Drugs Market
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian